SLRX icon

Salarius Pharmaceuticals
SLRX

Overview Fund Trends Analyst Outlook Journalist POV

6 hedge funds and large institutions have $48.4K invested in Salarius Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$20.2K
2
+$11.6K
3
+$8.67K
4
TRCT
Tower Research Capital (TRC)
New York
+$2.51K

Top Sellers

1
-$13
2
-$2
3
-$2
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$25.5K
TSS
2
Two Sigma Securities
New York
$11.6K
Geode Capital Management
3
Geode Capital Management
Massachusetts
$8.67K
TRCT
4
Tower Research Capital (TRC)
New York
$2.51K
Osaic Holdings
5
Osaic Holdings
Arizona
$120
Bank of America
6
Bank of America
North Carolina
$9
Morgan Stanley
7
Morgan Stanley
New York
$5
SS
8
SBI Securities
Japan
$1
BlackRock
9
BlackRock
New York
$1